Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

US Patent 8431134 · Granted Apr 30, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR inhibitors for the treatment of cancer2025
Compounds2025
EGFR inhibitor for the treatment of cancer2025
Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conj2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant canc2025
Systems and methods for cybersecurity risk assessment2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2024
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugat2023
Isoxazolyl ether derivatives as GABAA α5 PAM2023
Systems and methods for cybersecurity risk assessment2023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds2023